Most Recent
Energy Queensland unit fights probe into Centrepay charges
Ergon Energy is challenging a notice from the energy regulator in its probe of payments received via a Centrelink direct debit scheme, after AGL was fined $25 million for overcharging welfare recipients.
Bakers Delight challenges reverse onus finding in Fair Work case
Bakers Delight has filed a challenge to a finding that it was subject to a statutory reverse onus aimed at employers, in a Fair Work Ombudsman underpayments case against a franchisee.
Appeals court won’t revive defamation claims against AFP commander
A Melbourne couple whose defamation claims against an AFP commander were thrown out by a jury has had their appeal rejected.
Construction PRO
Drivas plans for add-on to Parramatta Square heritage site refused again
Property developer Drivas has lost its court fight over plans for a nine-storey tower atop the heritage-listed Murrays Building in Parramatta's Centenary Square.
Pilatus wins discovery for potential IP suit linked to Air Force contract
Swiss aircraft manufacturer Pilatus has won discovery to pursue a possible copyright claim stemming from a Royal Australian Air Force flight simulator contract.
Monsanto’s condition on Roundup class action discontinuance unfair, judge says
A judge has discontinued a second class action against Monsanto over its Roundup weed killer, but rejected the company's bid for an order that group members be barred from bringing similar claims.
‘I have taken it all’: Lawyer struck off roll after gutting trust account
A Sydney lawyer who was found to have fleeced nearly $500,000 from his clients’ trust accounts has been declared unfit for the profession.
Baker McKenzie, others win $3.5M security in Armour takeover case
A shareholder and creditor of failed energy company Armour Group will have to front $3.5 million in security in its case against law firm Baker McKenzie and others ahead of an upcoming trial.
Novartis appeals IP win for Pharmacor over blood pressure drug
Pharmaceutical giant Novartis is challenging the loss of its case against Sydney-based generics company Pharmacor over a patent for heart medication Entresto.